• Plerixafor (AMD3100): Redefining Platelet Trafficking and Tu

  2026-07-15

  Explore the advanced role of Plerixafor (AMD3100) in modulating platelet extravasation and the tumor microenvironment, extending beyond stem cell mobilization. This article delivers unique, evidence-based insights for cancer and immunology researchers.

• Perphenazine (SKU B6157): Reliable Solutions for Cell Assays

  2026-07-15

  This scenario-driven article explores how Perphenazine (SKU B6157), a dopamine D2 receptor antagonist, addresses key challenges in cell viability, proliferation, and host-pathogen interaction assays. Drawing on quantitative data and recent research, the article provides rigorous best practices for biomedical researchers seeking reproducibility and mechanistic clarity in neuropharmacology and immunology workflows.

• GOT1 Inhibition by Ziprasidone Disrupts Glutamine Metabolism

  2026-07-14

  This study identifies ziprasidone as a novel non-competitive inhibitor of glutamate-oxaloacetate transaminase 1 (GOT1) in pancreatic ductal adenocarcinoma (PDAC) cells, leading to impaired glutamine metabolism and suppressed tumor growth. The findings highlight GOT1 as a promising metabolic target for PDAC therapy and provide mechanistic insights relevant for metabolic cancer research.

• Masitinib (AB1010): Technical Use in KIT/PDGFRα/β Research

  2026-07-14

  Masitinib (AB1010) is a selective phenylaminothiazole-type tyrosine kinase inhibitor for precise inhibition of KIT, PDGFRα, and PDGFRβ in research models. It is best suited for DMSO-based cancer, mastocytosis, and inflammatory disease workflows requiring strict kinase selectivity, and should not be used in aqueous or ethanol-based protocols, or when broad-spectrum inhibition is needed.

• Spider Toxin v-Agatoxin-IVA and N-Type Ca Channel Blockade:

  2026-07-13

  Sidach and Mintz (2000) reveal that the spider toxin v-Agatoxin-IVA, long considered a highly selective P-type calcium channel blocker, also exhibits low-affinity blockade of N-type channels at higher concentrations. This nuanced pharmacological profile has significant implications for experimental design and the interpretation of calcium channel studies in neuronal systems.

• Controlled Balance of Renewal and Differentiation in Human I

  2026-07-13

  This study introduces a tunable system for human intestinal organoids that achieves a controlled balance between stem cell self-renewal and differentiation. By leveraging small molecule pathway modulators, the research demonstrates scalable, high-diversity organoid cultures suitable for advanced modeling and screening applications.

• Protease Inhibitor Cocktail: Precision for Protein Degradati

  2026-07-12

  The Protease Inhibitor Cocktail (100X in DMSO, EDTA plus) delivers comprehensive protection against proteolysis, empowering researchers to safeguard protein integrity in demanding workflows like Western blotting and co-immunoprecipitation. Its dual-component design and broad-spectrum inhibition capabilities make it an essential tool for reliable protein analysis, especially in studies targeting molecular chaperone networks.

• Partial BACE Inhibition Reduces Amyloid Beta Without Synapti

  2026-07-10

  Satir et al. (2020) demonstrate that moderate inhibition of the BACE1 enzyme can lower amyloid beta production by up to 50% without affecting synaptic transmission in cultured neurons. This finding refines strategies for Alzheimer's disease treatment research by suggesting a therapeutic window where amyloid reduction is achieved without compromising neuronal function.

• Safe DNA Gel Stain: Elevating Molecular Biology Through Safe

  2026-07-09

  Explore how Safe DNA Gel Stain advances DNA and RNA gel staining with exceptional safety and sensitivity. This article reveals distinct scientific insights and practical protocols, highlighting the stain’s role in improving molecular biology workflows.

• Viral Modulation of RIPK3: New Insights into Necroptosis Con

  2026-07-09

  Liu et al. identify a class of orthopoxvirus proteins that target and degrade RIPK3, suppressing necroptosis and regulating inflammation during viral infection. This work reveals a pivotal viral immune evasion strategy and opens new avenues for manipulating cell death pathways in infection biology.

• Salvianolic Acid B Inhibits LH2 to Mitigate Pulmonary Fibros

  2026-07-08

  This study elucidates how Salvianolic acid B (Dan Shen Suan B) acts as a potent antifibrotic agent by inhibiting lysyl hydroxylase 2 (LH2), disrupting pathological collagen cross-linking in pulmonary fibrosis. These findings provide a mechanistic basis for targeting LH2 in fibrosis research and highlight the translational potential of natural products for extracellular matrix remodeling.

• Translating Topoisomerase I Inhibition: Topotecan’s Strategi

  2026-07-08

  This thought-leadership article explores the mechanistic underpinnings and translational research strategies surrounding Topotecan (SKF104864). We integrate evidence-backed recommendations, protocol insights, and a competitive analysis to empower researchers focused on apoptosis induction in glioma cells and pediatric solid tumor models. The discussion bridges basic science, workflow optimization, and strategic guidance for clinical translation, with a critical outlook on future innovation.

• Dehydroepiandrosterone (DHEA): Protocols and Innovations in

  2026-07-07

  Leverage Dehydroepiandrosterone (DHEA) for advanced research in granulosa cell biology and neuroprotection with evidence-driven protocols. This article translates recent breakthroughs into actionable workflows, troubleshooting strategies, and comparative insights for maximizing the impact of DHEA in ovarian and neural models.

• FK866 (APO866): Resolving NAMPT Inhibition Challenges in AML

  2026-07-07

  FK866 (APO866, SKU A4381) is a validated, non-competitive NAMPT inhibitor widely used for reliable modulation of NAD biosynthesis in hematologic cancer research. This scenario-driven article details best practices, protocol insights, and troubleshooting strategies for cell viability, proliferation, and cytotoxicity workflows that leverage FK866—ensuring reproducibility and high-quality data for acute myeloid leukemia (AML) and related studies.

• Bleb Structures in LNP-mRNA Enhance Transfection Potency

  2026-07-06

  This study demonstrates that inducing mRNA-rich 'bleb' structures in lipid nanoparticle (LNP) formulations—using high-concentration pH 4 buffers like sodium citrate—significantly improves transfection efficiency in vitro and in vivo. The findings highlight a formulation-dependent mechanism for enhancing mRNA stability and delivery, with direct implications for the design of next-generation bioluminescent reporter mRNA systems.

447 records 11/30 page Previous Next First page 上5页 1112131415 下5页 Last page